Smith-Lemli-Opitz Syndrome and Cholic Acid

Clinical trial NCT03720990 · COMPLETED

Trial details

NCT number: NCT03720990
Sponsor: University of Nebraska
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Smith-Lemli-Opitz Syndrome

Start date: 2021-03-27
Primary completion: 2022-08-30
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.